CARDINAL, JOHN R.,JAMES, JACK LAWRENCE,MELSOPP, ELSIE,OAKLEY, DAVID M.
申请号:
CA2746855
公开号:
CA2746855C
申请日:
2009.12.18
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present invention provides matrix-forming, sustained-releasepharmaceutical formulations comprising four primarycomponents: i) an effective amount of at least one drug substance; ii) atleast one pharmaceutically acceptable, water-swellable,pH independent polymer; iii) at least one pharmaceutically-acceptable,anionic, pH dependent polymer; and (iv) apharmaceutically-acceptable polymer selected from the group consisting of a)at least one pharmaceutically-acceptable cationicpolymer; and b) at least one pharmaceutically acceptable hydrocolloid. Thepresent formulations can be used with compounds having awide range of solubilities as well as compounds characterized as havinghydrophobic or hydrophilic characteristics.